ResQ Pharma, a research and development company, was founded with the mission to save lives by providing innovative medical solutions. The company's core product, LipidRescue Therapy (LRT), is an investigational antidote designed to treat various non-opiate drug overdoses and poisonings, including those caused by local anesthetics, benzodiazepines, and psychotherapeutics. ResQ Pharma focuses on advancing this therapy to address critical needs in emergency medicine and toxicology.
Notable figures affiliated with ResQ Pharma include experts in pharmacology and toxicology who have contributed to the development of LipidRescue Therapy. The company has garnered attention from investors interested in life-saving medical innovations. Key achievements include the progression of LipidRescue Therapy through various stages of research and development, although it is still awaiting FDA approval. ResQ Pharma's impact lies in its potential to revolutionize the treatment of drug toxicity and save countless lives.
